Serpine-1 (=PAI1) has been associated with breast cancer clinical outcome and is involved in the interactions between the tumor and its microenvironment, particularly in breast cancer (Vénat-Bouvet et al., 2012; Ferroni et al., 2014). Here, SERPINE1 is linked to breast cancer.